{"id":"W4399361815","doi":"10.1016/j.esmoop.2024.103488","title":"An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"National Cancer Institute; AstraZeneca; Incyte; Amgen","keywords":"Medicine; Cohort; Clinical endpoint; Internal medicine; Oncology; Adverse effect; Progression-free survival; Retrospective cohort study; Surgery; Gastroenterology; Overall survival; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002161544,0.001193082,0.001547304,0.0002965287,0.0004018655,0.0008855943,0.0005693486,0.0009270082,0.002960789],"category_scores_gemma":[0.0009053753,0.0004186334,0.001539257,0.0003613228,0.0006733166,0.000766203,0.0003672897,0.001964501,0.0006874085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007502303,"about_ca_system_score_gemma":0.00119217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007655961,"about_ca_topic_score_gemma":0.002913375,"domain_scores_codex":[0.9995155,0.0002092278,0.00003504623,0.00006928909,0.0000737677,0.00009711371],"domain_scores_gemma":[0.9991066,0.0001298069,0.0001862224,0.0001154931,0.00009920671,0.0003626219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6655074,0.05872202,0.02175551,0.002518839,0.004347227,0.0008319909,0.0004321904,0.002303945,0.08712415,0.0006297188,0.01158404,0.1442429],"study_design_scores_gemma":[0.4947063,0.4390685,0.03985189,0.0001222537,0.001588331,0.001038715,0.0001545863,0.001025751,0.009016568,0.0003657594,0.0129876,0.00007372732],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852229,0.003767455,0.0007523212,0.0004039089,0.0001445019,0.002637301,0.00374004,0.0001104208,0.003221069],"genre_scores_gemma":[0.9779131,0.002446421,0.002344797,0.001321706,0.0002583075,0.002701444,0.009449823,0.00005128245,0.003513146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002960789,"threshold_uncertainty_score":0.01143152,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1468446751598439,"score_gpt":0.404070658401311,"score_spread":0.2572259832414672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}